Tumor-infiltrating B lymphocytes promote melanoma progression & resistance to therapy

(The Wistar Institute) In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified the role of tumor-infiltrating or tumor-associated B-cells ('TABs') in melanoma progression and resistance to targeted therapy.
Source: EurekAlert! - Biology - Category: Biology Source Type: news